Price movement15 Sep 2025 11:07
As the announcement was released today (September 15, 2025), real-time market data is limited, and no immediate post-announcement trading reactions were captured in searches up to this point. However, based on historical patterns for Ondine Biomedical's stock (OBI.L) in response to similar positive clinical and efficacy news for SteriWave, the share price is likely to experience a positive reaction, potentially an upward movement of 10-30% in the short term (e.g., intraday or over the next 1-3 trading days).